Bronchodilating effect of ipratropium bromide inhalation powder and aerosol in children and adolescents with stable bronchial asthma
| Autor: | Charlotte Suppli Ulrik, Vibeke Backer, N. Bach-Mortensen |
|---|---|
| Rok vydání: | 1992 |
| Předmět: |
Male
Adolescent Bronchoconstriction Immunology Ipratropium bromide Double-Blind Method Forced Expiratory Volume medicine Humans Immunology and Allergy Outpatient clinic Child Adverse effect Fenoterol Asthma Aerosols Inhalation business.industry Ipratropium Nebulizers and Vaporizers Respiratory disease respiratory system medicine.disease Metered-dose inhaler respiratory tract diseases Anesthesia Female Bronchial Hyperreactivity business medicine.drug |
| Zdroj: | Allergy. 47:133-137 |
| ISSN: | 1398-9995 0105-4538 |
| Popis: | Ulrik CS, Backer V, Bach-Mortensen N. Bronchodilating effect of ipratropium bromide inhalation powder and aerosol in children and adolescents with stable bronchial asthma. The purpose of this study was to compare the bronchodilating effect of ipratropium bromide (IB) administered by a conventional Ingelheim powder device system (IPI) and by a metered dose inhaler (MDI) in children and adolescents with stable bronchial asthma. Seventy patients, aged 7 to 16 years, with stable bronchial asthma from our outpatient clinic were tested for bronchial responsiveness to inhaled IB. Fifteen (21%) of the 70 subjects were found to have a substantial bronchial response to inhalation of 40 γg IB, i.e. at least 15% increase in FEV1 30 min after inhalation; the remaining 55 subjects had |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text